All Resources

Economic Impact • June 12, 2025

Open Letter

Learn more | View

Access to Medicine • March 10, 2025

Increasing Access to Innovative Medicines

Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget…

Learn more | View

Private Drug Coverage • November 04, 2024

Issues and Opportunities to Modernize Private Drug Plan Sustainability 2024

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • January 04, 2024

IMC Response to the PMPRB’s 2023 Scoping Paper for the Consultations on the Board’s Guidelines

Learn more | View

Access to Medicine • October 19, 2023

Cost Drivers Report 2023

Annual cost growth in Canada’s private drug benefit market is driven by increased utilization and chronic disease drugs, with an increase in claimants post‑pandemic. Read the full report….

Learn more | View

Access to Medicine • September 28, 2023

Value of Medicines in Canada

Learn more | View

Private Drug Coverage • September 15, 2023

Cost of A Private Drug Plan Claim

Learn more | View

Access to Medicine • August 21, 2023

pCPA Temporary Access Process: Innovative Medicines Industry Consultation Response

Learn more | View

Pharmacare • June 01, 2023

Addendum to Innovative Medicines Canada Submission on National Pharmacare

Learn more | View

Access to Medicine • May 16, 2023

Developing a Canadian managed entry approach for new innovation: What can Canada learn from Europe?

Learn more | View

Access to Medicine • May 02, 2023

Clinical Trials in Canada

Learn more | View

Access to Medicine • February 15, 2023

Increasing Access to Innovative Medicines

Learn more | View